ONPATTRO Trademark

Trademark Overview

On Friday, March 18, 2016, a trademark application was filed for ONPATTRO with the United States Patent and Trademark Office. The USPTO has given the ONPATTRO trademark a serial number of 86944919. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 7, 2025. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The ONPATTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
onpattro

General Information

Serial Number86944919
Word MarkONPATTRO
Filing DateFriday, March 18, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 7, 2025
Registration Number5596122
Registration DateTuesday, October 30, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2016
Primary Code005
First Use Anywhere DateMonday, August 13, 2018
First Use In Commerce DateMonday, August 13, 2018

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, July 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2016NEW APPLICATION ENTERED
Wednesday, March 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 29, 2016ASSIGNED TO EXAMINER
Wednesday, July 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2016PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 15, 2017SOU EXTENSION 1 GRANTED
Tuesday, October 4, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 15, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, March 15, 2017SOU EXTENSION 1 FILED
Friday, March 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 14, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, September 19, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, September 19, 2017SOU EXTENSION 2 FILED
Tuesday, September 19, 2017SOU EXTENSION 2 GRANTED
Thursday, September 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, March 14, 2018SOU EXTENSION 3 FILED
Wednesday, March 14, 2018SOU EXTENSION 3 GRANTED
Friday, March 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 14, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 14, 2018USE AMENDMENT FILED
Sunday, September 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, September 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, September 21, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 22, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 4, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 7, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 7, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, October 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 18, 2024TEAS SECTION 8 & 15 RECEIVED

Related Keywords

onpattro pharmaceutical treatment preparations amyloidotic polyneuropathy familial mediated transthyretin amyloidosis